Summary
Overview
Work History
Education
Skills
Presentationspublicationsawards
Membershipsappointments
Timeline
Generic

Maureen Doyle Scharff

Delaware,OH

Summary

Dynamic leader with a proven track record at Pfizer Inc, excelling in client engagement and change management. Spearheaded the transformative global medical grants program, enhancing health equity and patient care worldwide. Expert in quality improvement and continuing medical education, demonstrating exceptional communication skills and a commitment to excellence.

Overview

28
28
years of professional experience

Work History

Group Lead, Executive Director

Office of Global Medical Grants & Partnerships, Institute of Translational Equitable Medicine Pfizer Inc
New York City, NY
01.2007 - Current
  • Provides leadership, expertise, inspiration and oversight for the conceptualization, management, development and implementation of Pfizer’s global independent research and learning & change strategy
  • Collaborates with key internal and external stakeholders for learning & change planning and the assessment of patient-level outcomes to ensure the independent grants program supports Pfizer’s broad-based efforts to improve quality and patient care in prioritized areas
  • Leads Pfizer’s unique Research Collaboration program that involves pre-clinical, PCO, clinical, health services, RWE, outcomes research
  • Identifies and defines externally validated gaps that lead to the development of goals and strategies to close those gaps; provides consultative advice to medical affairs, research and business units, recommends strategic direction for key clinical and medical teams, and ensures achievement of budget targets
  • Develops and maintains partnerships with key external stakeholders (academic institutions, professional organizations, health systems, payers, government), fosters an understanding of Pfizer’s goal to improve care through collaboration and partnerships
  • Ensures compliance with all government and internal policies and procedures; serves as subject matter expert in all things related to independent medical education for global compliance and legal colleagues
  • Manages a budget of approximately $250 Million USD annually
  • Key accomplishments include:
  • Redesigned and implemented the Institute of Translational Equitable Medicine focused on the science behind health disparities and translating new data and information to improve patient outcomes globally
  • Developed, implemented and lead a partnership and collaboration program that is considered the gold standard in the pharmaceutical industry
  • Established an Outcomes & Analytic function of the GMG program that leverages structured and unstructured data captured through our grants and collaboration programs to inform future strategies and investments
  • Transformed traditional medical education grants program, whose measure of success was based more on how many HCPs were reached with education than how patient care was improved, into a program that leverages the science of learning and change to focus efforts on closing gaps in care through education, performance improvement and quality improvement initiatives
  • After several years of successful implementation of the learning & change model in the US, as well as key pilots in Europe and Asia, received support and approval from senior business leaders to expand the IGLC scope across the world
  • In 2015, negotiated a finance scheme that increases Pfizer Learning & Change investment from $40 Million to $80 Million over 3 years (matching funds model)
  • In 2016, assumed responsibility for Pfizer’s entire global independent grants program, including clinical research and research collaborations
  • Established the industry’s first end-to-end independent grants program bringing clinical research, health services research, education and quality/practice improvement together in a single program
  • Strategies focus on gaps in data, gaps in knowledge and gaps in practice and how each solution tangibly leads to the other
  • Program measures success at the patient level, either directly or indirectly improving care and outcomes on a global scale
  • Established trusted, consultative relationships with key internal leaders across all Business Units (Innovative Products, Established Products, Vaccines) and WRD
  • Negotiated and established partnerships with key external stakeholders, seeking common ground, overlapping goals, and a desire to shift the culture relative to how the healthcare community works with Pfizer
  • Key partners include: The Joint Commission, American Academy of Pediatrics, Institute for Healthcare Improvement, Blue Cross Blue Shield, Aetna, HHS and CDC, among many others

Director

Abbott Laboratories, Abbott Nutrition
Columbus, OH
01.2005 - 01.2007
  • Development and implementation of division-wide strategies and multi-year plan for healthcare/medical education activities that support business goals and objectives
  • Includes an ongoing Healthcare Education Process Improvement Initiative that addresses quality, cost-efficiencies, compliance and legal implications
  • Lead and manage the Healthcare Education efforts to develop and/or support medical education that complies with all appropriate internal and external guidelines and requirements, is innovative and cost effective
  • Development and implementation of division-wide strategies and a multi-year plan for public policy and government relations, which enable Ross Products Division (RPD) to proactively manage the dialog with and influence key policy makers
  • Critical to success is gaining alignment and compliance from key constituents, including the Division President and the Business Unit General Managers
  • Development and implementation of division-wide strategies and a multi-year plan for professional relations, which will strengthen RPD relationships with key industry associations and advocacy groups
  • Critical to this strategy is gaining alignment and compliance from key constituents, including the Division President and the Business Unit General Managers
  • This includes evaluating strategies to address health care professional groups during their training/residency to begin building relationships with future health care decision makers
  • Lead a staff of 22; oversee the development and implementation of, and manage the operating budget for the Health Education, Policy & Programs staff ($6 Million), and brand/sales budgets ($1 Million)
  • Additional medical education responsibilities include:
  • Strategic planning for medical education (independent and promotional) as an integral component of Business Unit and Brand planning process
  • Collaboration with internal departments to determine focus of medical education strategy, conduct needs assessments (as required), determine appropriate methodology, and viable partner, vendor, provider.

Executive Director

Alliances & Advocacy, Johnson & Johnson, Biopharmaceutical Public Policy
New Brunswick, NJ
01.2003 - 01.2005
  • Responsibilities included:
  • Design, develop, facilitate and maintain a strategic, transparent, cross-functional framework that promotes intra- and inter-company collaboration within the medical education, professional alliance/patient advocacy, academic medicine, and government affairs arenas
  • Differentiate J&J with associations through the design and development of customer solutions that leverage the strength of multiple J&J companies and help to drive business across customer segments
  • Develop and manage strategic relationships with leadership of key constituents including national, regional/state professional and patient organizations, in concert/collaboration with J&J Company counterparts who manage tactical relationships
  • Primarily US Market focus with some International responsibilities
  • Consultant to internal J&J Med Ed teams on strategy, quality, outcomes and compliance issues related to CME/CPD

Director

Global Professional Affairs, Pharmacia Corporation
Peapack, NJ
01.2000 - 01.2003
  • Establish, monitor, and lead the implementation of strategy and goals for Professional Affairs, a field-based team responsible for developing strategic partnerships with national, regional and state-level professional associations and patient advocacy organizations, in support of the business strategy established for U.S
  • Market Operations
  • Lead and coach by expanding the knowledge base of Professional Affairs personnel relative to internal/external resources that will enhance their ability to better understand their customer’s needs, effectively influence their customer base, leverage customer relationships and strengthen the competitive advantage of Pharmacia in selected markets
  • Facilitate a Pharmacia strategy that leverages strategic alliances with 3rd party organizations on short and long-term legal and political issues to increase support for our products, our company and the pharmaceutical industry
  • Represent Pharmacia as a member of the PhRMA Alliance Development Section
  • Provide accurate and timely information to appropriate U.S
  • Market Company leaders on specific Professional Affairs activities, goals and accomplishments
  • Oversee the development and implementation of, and manage the operating budget for the PA organization ($3.5 Million), and brand budgets ($2.5 Million).

National Education Manager

Pharmacia Corporation
01.1998 - 01.2000

Production Management Team Leader

Market Consulting Services, Pharmacia & Upjohn
Kalamazoo, MI
01.1997 - 01.1998
  • Leadership responsibilities include:
  • Management of 10 team members including hiring, training and development
  • Design process and functionality of production team that supported MCS in addition to account management, sales and marketing
  • MCS Leadership Team member: strategy development, budget management, human resource issues
  • Additional responsibilities:
  • Development and implementation of assessment surveys, marketing materials and National education programming (Distance Learning, national symposia/congress, faculty development courses)

Operations Manager

Pharmacia Corporation
Peapack, NJ
  • Leadership responsibilities include:
  • Strategic and tactical responsibilities for professional education initiatives with designated brand teams (Celebrex/Arthritis+Pain, Vestra/Depression, Axert/Migraine, Women’s Health/HRT+Contraception, Detrol/Overactive Bladder, Camptosar/Oncology)
  • Tactical implementation of work flow processes that maximize the output and quality of Healthcare Education Consulting (HEC) deliverables
  • Strategic and vendor alliance relationships that enhance the value of HEC deliverables
  • Primary/secondary contact with internal Pharmacia business teams: GBM, Sales, MAM, AHOM to allow for timely development and implementation of educational strategies nationally
  • Maintenance and continuous improvement of an education ROI analysis model that efficiently and effectively provides investors with a reliable measure of ‘impact’ relative to education in the healthcare market
  • Additional responsibilities:
  • Account Management support: develop and maintain relationships with customers using educational initiatives, tools and skills to implement behavioral change
  • This consultative process benefits managed care organizations and patients, as well as Pharmacia by providing deeper access to upper level management and increased business opportunities with key managed care companies
  • Planning, organizing and preparing the annual HEC Operations plan; development of key HEC national and regional planning meetings, and coordination of HEC training programs; budget management; chair of the following HEC councils: CNS, Women’s Health, Education Technologies

Central Support Team Leader

Healthcare Education Services, Pharmacia & Upjohn
Kalamazoo, MI
  • Leadership responsibilities include:
  • Management and implementation of all Central Support processes (team of 3) for healthcare provider education nationally, supporting P&U Regional Sales requests for community level educational interventions
  • Development of an evaluation and reporting process to determine behavioral change/ROI with regard to interventions produced
  • Additional responsibilities:
  • Management of P&U Distance Learning program, including all emerging technology issues (e.g., internet) relating to provider education
  • Development of enduring materials and self-directed learning programs, which support P&U business plans and educational/sales objectives
  • Acquire appropriate certification through external partnerships, relying on a thorough knowledge and understanding of all FDA and ACCME rules and guidelines, as well as internal medical, legal and regulatory review process
  • Management of the HES Resource Center, including the development of numerous databases (faculty, DesignWorks Registry, PRS Registry), speaker support materials (slides, monographs), conversion of tools to electronic-based interface
  • Sales training on continuing medical education

Director of Operations

Improvisions Inc
Kalamazoo, MI
  • Daily operations of a medical education/marketing communications firm
  • Management of approx
  • 15 staff members including staff writers, production artists, designers, proofreaders, production coordinators and fulfillment/assembly staff
  • Additional responsibilities:
  • Account director for several Fortune 500 companies including The Upjohn Company/Pharmacia & Upjohn (primary client), Eaton Corporation, Steelcase Inc., and Kellogg Company
  • Duties included sales, conceptualization, project coordination, meeting/event planning, process implementation, writing and evaluation/summary reports
  • Development, implementation of medical education activities
  • Development, implementation and maintenance of all vendor relationships
  • Coordination of all marketing and advertising interests for the company

Education

PhD - Higher Education Leadership and Administration

Ohio University
Athens
01.2017

NextGen -

Pfizer Leadership Development Program
01.2014

MBA - Pharmaceutical Marketing

St. Joseph University
Philadelphia
01.2006

BFA - Graphic Arts

University of Michigan
Ann Arbor
01.1986

Skills

  • Client Engagement
  • Quality Improvement Initiatives
  • Verbal and written communication
  • Change management expertise
  • Health Equity Implementation
  • Continuing medical education

Presentationspublicationsawards

  • The Evolving Role of Medical Education in the Pharmaceutical Industry, 08/01/21, IFAPP Academy-King´s College London Medical Affairs in Medicines virtual lecture
  • Women and Leadership Half-day Workshop, 01/01/19, ACEhp Annual Conference, Washington DC
  • Mock Grant Review Panel: Part 2, 05/01/16, Alliance Industry Summit, Philadelphia, PA
  • Global Medical Education panel, 05/01/16, Alliance Industry Summit, Philadelphia, PA
  • An Update on the GAME Regional Conference – India, 03/01/16, Global CME Congress, San Diego, CA
  • EFPIA and CME: A Conversation with Marie Claire Pickaert, 11/01/15, European CME Forum, Manchester
  • Mock Grant Review Panel, 05/01/15, Alliance Industry Summit, Philadelphia, PA
  • CME in Europe; Is There a Role for Industry?, 02/01/15, UEMS Consensus Conference
  • The Amazing Race Workshop, 01/01/15, ACEhp Annual Conference, Dallas, TX
  • Industry’s Role in CME: A Conversation with Murray Kopelow, MD, 11/01/14, European CME Forum, London
  • Women faculty in STEM and the value of mentoring in advancing the field, 10/27/14, Mentoring for the Professions: Orienting Toward the Future

Membershipsappointments

  • President, Board of Directors, Commission for Certification of Healthcare CPD Professionals, 01/01/12, 12/31/16
  • Founder, President, Ohio Affiliate/Chapter, Healthcare Business Women’s Association (HBA), 01/01/06, 12/31/09
  • Member, CME Leadership Planning Committee, Annenberg Center for Health Sciences at Eisenhower, 01/01/06, 12/31/10
  • Member, AMA CME Provider/Industry Collaboration Taskforce, 01/01/04, 12/31/13
  • Member, California Academy of Family Physicians (CAFP) Education Advisory Board, 01/01/04, 12/31/10
  • Member, American Osteopathic Association (AOA) Industry Advisory Board, 01/01/03, present
  • Member, American Podiatric Medical Association (APMA) Industry Advisory Board, 01/01/02, 12/31/10
  • Member, Healthcare Business Women’s Association (HBA), 01/01/01, present
  • Member, AMA Working Group on Communication of Ethical Guidelines for Gifts to Physicians from Industry, 01/01/01, 12/31/06
  • Member, PhRMA Alliance Development Section, 01/01/01, present
  • Board of Directors, Alliance for Continuing Education in the Health Professions (ACEhp), 01/01/97, 12/31/10
  • Board of Directors, Global Alliance for Medical Education (GAME), 01/01/02, 12/31/17

Timeline

Group Lead, Executive Director

Office of Global Medical Grants & Partnerships, Institute of Translational Equitable Medicine Pfizer Inc
01.2007 - Current

Director

Abbott Laboratories, Abbott Nutrition
01.2005 - 01.2007

Executive Director

Alliances & Advocacy, Johnson & Johnson, Biopharmaceutical Public Policy
01.2003 - 01.2005

Director

Global Professional Affairs, Pharmacia Corporation
01.2000 - 01.2003

National Education Manager

Pharmacia Corporation
01.1998 - 01.2000

Production Management Team Leader

Market Consulting Services, Pharmacia & Upjohn
01.1997 - 01.1998

Operations Manager

Pharmacia Corporation

Central Support Team Leader

Healthcare Education Services, Pharmacia & Upjohn

Director of Operations

Improvisions Inc

PhD - Higher Education Leadership and Administration

Ohio University

NextGen -

Pfizer Leadership Development Program

MBA - Pharmaceutical Marketing

St. Joseph University

BFA - Graphic Arts

University of Michigan

Similar Profiles

CREATE PROFILE
Maureen Doyle Scharff